• News
  • Movies
  • Money
  • Health
  • Videos
More
  • Health News
  • Features
  • Food
  • Wellness
  • Diseases
  • Pregnancy
  • Parenting
  • Mental Health
  • Stress

India readies 5 sites for final phase of human trials of Oxford COVID vaccine

Jul 28, 2020, 09:04 AM IST
T- T T+
COVID
X
×

New Delhi: Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.

This is an essential step because it is necessary to have data within the country before the vaccine is administered to Indians, Ms Swarup told PTI.

The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready. Trials results for the first two phases were published earlier this month.

According to Ms Swaroop, the DBT is part of any COVID-19 vaccine effort in India "... whether it is funding, whether it is facilitating the regulatory clearances or whether it is giving them access to different networks which exist within the country".

"The DBT is now setting up Phase 3 clinical sites. We have already started working on them and five sites are now ready to be available for Phase 3 trials," Ms Swarup told PTI in a telephonic interview.

The Pune-based SII has also sought permission from the Drugs Controller General of India (DCGI) for conducting Phase 2 and 3 of human clinical trials of the potential vaccine.

It had said earlier it will start manufacturing the vaccine even before the final nod so it is ready with sizable volumes once the vaccine gets all permissions.

"DBT is closely working with every manufacturer and Phase 3 trial of Serum (institute) is important because if the vaccine has to be successful and it has to be given to the Indian population we need to have the data within the country.

"For that a Phase 3 trial has been proposed. Five sites are ready. Within some more weeks, they should be ready for manufacturers to take them up for clinical trial studies," the DBT secretary said.

On July 20, scientists announced that the coronavirus vaccine developed by Oxford University appears safe and induces a strong immune response within the body after the first phase of "promising" human trials against the deadly disease that has infected over 1.45 crore people across the world and claimed more than six lakh lives.

Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five UK hospitals in April and May as part of the Phase 1 clinical trial and results, published in The Lancet medical journal.

The results show they induced strong antibody and T-cell immune responses for up to 56 days after they were given.

Scientists behind the trials found the response could be even greater after a second dose.

In Phase 1 of human trials, a vaccine is given to a small number of people to test safety. It is also given to check if it stimulates the immune system.

In the second phase, it is administered to hundreds of people split into groups such as children and the elderly to see if the vaccine acts differently in them. The two phases focus on safety and immunogenicity in humans.PTI

PRINT
EMAIL
COMMENT
 

Related Articles

2,24,301 beneficiaries given COVID-19 vaccine so far; 447 cases of adverse effect reported: Govt
News |
Movies & Music |
98-year-old Mollywood actor Unnikrishnan Namboothiri defeats COVID-19
News |
Kerala reports 5,005 new Covid-19 infections; test positivity rate at 9.57 percent
News |
Congress alleges govt procuring Covid vaccine at inflated prices
 
 
  • Tags :
    • Coronavirus
More from this section
Covaxin
Covaxin efficacy meets WHO standards, safe to use: Joint Drugs Controller
vaccine
COVID-19 vaccine race: Main candidates and where they stand
Telemedicine Services
Huge demand for telemedicine service in Kerala; 70,000 patients utilise facility
covid
Most hospitalised COVID-19 patients have at least one symptom 6 months after falling ill: Study
bird flu
Bird flu: Well-cooked meat, egg can be consumed
News in Videos
News+ Kerala India NRI World Columns Features Offbeat Good News Crime
Leisure Movies & Music Sports Travel Books
Learn Money Education Agriculture
Lifestyle Health Tech Food Astrology
Multimedia Gallery Videos Mojo News News In Pics
Our Network Malayalam Print Mathrubhumi News TV Kappa TV Club FM Seed Silver Bullet FindHome Media School MBIFL Redmic
E-Paper
Subscription
Buy Books
Magazines
Classifieds
Archives
 
  • E-Paper
  • Subscription
  • Buy Books
  • Magazines
  • Classifieds
  • Archives
© Copyright Mathrubhumi 2021. All rights reserved.
About Us Contact Us Privacy Policy
Terms of Use Archives
Ad Tariff Download App Classifieds
Buy Books Subscription e-Subscription
 
           
© Copyright Mathrubhumi 2021. All rights reserved.